Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

7 results
12:00 AM, Mar 07, 2016  |  BC Week In Review | Clinical News  |  Regulatory

Aczone dapsone topical gel regulatory update

12 …
The company already markets Aczone 5% in the U.S. and plans to launch the new product …
in May. Aczone is a topical gel formulation of sulfone. Allergan plc (NYSE:AGN), Dublin, Ireland   …
12:00 AM, Jun 16, 2008  |  BC Week In Review | Clinical News  |  Regulatory

Aczone dapsone topical gel regulatory update

Health Canada approved an sNDS from QLT to update the label for Aczone to remove the …
gel in March (see BioCentury, March 24). QLT Inc. (TSX:QLT; NASDAQ:QLTI), Vancouver, B.C.   Product: Aczone
12:00 AM, Mar 24, 2008  |  BC Week In Review | Clinical News  |  Regulatory

Aczone dapsone topical gel regulatory update

FDA approved an sNDA from QLT to update the label for Aczone to remove the glucose …
gel is marketed to treat acne vulgaris. QLT Inc. (TSX:QLT; NASDAQ:QLTI), Vancouver, B.C.   Product: Aczone
12:00 AM, Jul 30, 2007  |  BC Week In Review | Clinical News  |  Regulatory

Aczone dapsone topical gel regulatory update

remove the glucose 6-phosphate dehydrogenase (G6PD) screening and blood monitoring requirements from the label of Aczone
a decision by the end of March 2008 on the label change for the 5% dapsone topical gel
12:00 AM, Jun 04, 2007  |  BC Week In Review | Clinical News  |  Regulatory

Aczone dapsone topical gel regulatory update

QLT submitted an sNDA to FDA for Aczone to remove the glucose 6-phosphate dehydrogenase (G6PD) screening …
treat acne vulgaris. The company expects a decision in about 10 months for the 5% dapsone topical gel
12:00 AM, Jul 11, 2005  |  BC Week In Review | Clinical News  |  Regulatory

Aczone dapsone topical gel regulatory update

FDA approved an NDA for Aczone 5% dapsone topical gel to treat acne vulgaris. QLT will conduct a …
would not comment on when this trial would begin or when it planned to launch Aczone
12:00 AM, Sep 06, 2004  |  BC Week In Review | Clinical News  |  Regulatory

Aczone regulatory update

The partners submitted an NDA for Aczone 5% dapsone gel to treat acne. ATRX is being …
Laboratories Inc. (ATRX), Fort Collins, Colo.   Fujisawa Healthcare Inc. , Deerfield, Ill.   Product: Aczone